# VIRmiRNA: a comprehensive resource for experimentally validated viral miRNAs and their targets.

Abid Qureshi, Nishant Thakur, Isha Monga, Anamika Thakur, Manoj Kumar

<figure><img src="image_1.png" /></figure>

► To cite this version:

Abid Qureshi, Nishant Thakur, Isha Monga, Anamika Thakur, Manoj Kumar. VIRmiRNA: a comprehensive resource for experimentally validated viral miRNAs and their targets. Database - The journal of Biological Databases and Curation, 2014, 2014 (1-10), 10.1093/database/bau103. hal-01311117

HAL Id: hal-01311117

https://hal.science/hal-01311117

Submitted on 4 Jul 2023

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>
Original article

# VIRmiRNA: a comprehensive resource for experimentally validated viral miRNAs and their targets

Abid Qureshi†, Nishant Thakur†, Isha Monga†, Anamika Thakur and Manoj Kumar*

Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research, Sector 39-A, Chandigarh 160036, India

*Corresponding author: Tel: +91 172 6665453; Fax: +91 172 2690585; +91 172 2690632; Email: manojk@imtech.res.in

†These authors contributed equally to this work.

Citation details: Qureshi,A., Thakur,N., Monga,I., et al. VIRmiRNA: a comprehensive resource for experimentally validated viral miRNAs and their targets. *Database* (2014) Vol. 2014: article ID bau103; doi:10.1093/database/bau103

Received 2 April 2014; Revised 10 September 2014; Accepted 1 October 2014

## Abstract

Viral microRNAs (miRNAs) regulate gene expression of viral and/or host genes to benefit the virus. Hence, miRNAs play a key role in host-virus interactions and pathogenesis of viral diseases. Lately, miRNAs have also shown potential as important targets for the development of novel antiviral therapeutics. Although several miRNA and their target repositories are available for human and other organisms in literature, but a dedicated resource on viral miRNAs and their targets are lacking. Therefore, we have developed a comprehensive viral miRNA resource harboring information of 9133 entries in three subdatabases. This includes 1308 experimentally validated miRNA sequences with their isomiRs encoded by 44 viruses in viral miRNA 'VIRmiRNA' and 7283 of their target genes in 'VIRmiRtar'. Additionally, there is information of 542 antiviral miRNAs encoded by the host against 24 viruses in antiviral miRNA 'AVIRmir'. The web interface was developed using Linux-Apache-MySQL-PHP (LAMP) software bundle. User-friendly browse, search, advanced search and useful analysis tools are also provided on the web interface. VIRmiRNA is the first specialized resource of experimentally proven virus-encoded miRNAs and their associated targets. This database would enhance the understanding of viral/host gene regulation and may also prove beneficial in the development of antiviral therapeutics.

Database URL: http://crdd.osdd.net/servers/virmirna

## Introduction

RNA interference (RNAi) is a process in which short double stranded RNA inhibits gene expression of

complementary target sequence. After the discovery of RNAi in 1998 by Fire and Mello (1), the field has gained momentum owing to various molecules being reported to
regulate gene expression like microRNA (miRNA), small interfering RNA, Piwi-interacting RNA, long noncoding RNA etc. (2, 3). miRNAs are short double stranded 19-23 nucleotides long antisense molecules, which are endogenously produced and processed (4, 5). They function as regulators of gene expression by exhibiting perfect or nearly perfect base pairing with target mRNA, thus inhibiting its expression at post-transcriptional level by either mRNA degradation or translational repression (6, 7). Lin-4 was the first miRNA discovered in *Caenorhabditis elegans* to regulate the expression of *lin-14* protein coding gene (8). Subsequent research indicated that more than 30% of human protein-coding genes are regulated by miRNAs (9).

miRNAs play important roles in various biological processes like development, differentiation, growth, expression, cell division, stress conditions, apoptosis, cancer etc. (10, 11). They have been found to play an important role in viral infections and activation of innate immune response during disease progression (12). An increasing number of miRNAs encoded by viruses have been identified in the past. In 2004, it was found that Epstein-Barr virus (EBV) genome encodes many viral miRNAs for host/viral gene regulation (13), thereafter a number of viral miRNAs and their isomiRs were described in other viruses (14-16). IsomiRs are miRNA sequence variants that differ in length or nucleotides at the 5' and 3' miRNA termini and are generated from a miRNA precursor during maturation process (17). It has been reported that these isomiRs are functionally active and have evolutionary implications (18, 19).

Subsequently, host genes targeted by viral miRNAs have also been reported (20, 21). Thus, viral miRNAs help the virus to make a propagating environment in the host cell (16). Conversely, there are also reports of some antiviral miRNAs encoded by the host cell that inhibit viral pathogenesis as a means of defense mechanism (22, 23).

As miRNAs are important regulatory molecules, they may be helpful in developing novel therapeutics (24, 25). Recently, synthetic antimiRNA oligonucleotides (AMOs) have been reported to inhibit miRNAs (26). Similarly, targeting miR-122 has been reported as an antiviral strategy against hepatitis C virus (HCV) (27). miRNAs are also being exploited in other important areas like cardiac remodeling (28), inflammatory disease (29), fibrosis (30), neoangiogenesis (31) and various metabolic diseases (32). Miravirsen is the first miRNA-targeted drug to enter in the Phase IIa clinical trial with antiviral activity against HCV (24). Therefore, it would be important to have resources on viral miRNA that can prove helpful in developing antiviral therapeutics.

There are many repositories for experimental and predicted miRNAs; their cognate targets and associated interactions like miRBase (33), Plant miRNA database

(PMRD) (34), microRNA.org (35), TarBase (36), miRTarBase (37), mirDB (38), miRWalk (39), miRecords (40) etc., which encompass detailed information about the miRNAs found in different organisms. There are some repositories of predicted viral miRNAs and their targets like VirMirDb (41), vhotdb (42), miRNEST (43), ViTa (44) and RepTar (45) but a dedicated experimental viral miRNA archive along with their targets is lacking. Although miRBase comprehensively covers miRNAs from diverse organisms but with limited viral miRNA sequences. Likewise, miRTarBase (37) holds knowledge of miRNA targets from different organisms, but it has very few viral miRNA targets. Therefore, a dedicated experimental viral miRNA archive along with their targets is lacking. In this study, we have developed a specialized web resource covering information on various aspects of viral miRNAs, i.e. experimentally validated miRNAs, their associated targets and antiviral miRNAs.

# Material and methods

## Data search

Literature search was performed extensively to fish out articles related to viral miRNAs, viral isomiRs (miRNA variants), targets of viral miRNAs and antiviral miRNAs from PubMed/Patent Lens. We have used following query in advanced search option of PubMed:

((((((virus) OR viruses) OR virus*) OR viral)) AND
((((((microrna) OR microrna*) OR mirna) OR mirna*)
OR isomir) OR isomir*))

This query retrieved 3472 articles as on July 2014 that contains 703 review papers. We have screened these articles to shortlist over 600 potential articles after removing reviews. Articles having information pertaining to predicted miRNAs, modified nucleotides, general mechanism/ expression studies, structural studies etc. were not considered. Finally data was extracted from 204 research articles having the required information.

## Database organization

For lucid presentation, viral miRNA (VIRmiRNA) resource is organized into three different categories, namely VIRmiRNA, VIRmiRtar and AVIRmir to furnish experimentally validated information of viral miRNAs, their targets and antiviral miRNAs respectively. Broadly each module provides information regarding the following fields: (i) miRNA ID, (ii) virus, (iii) taxonomy, (iv) nomenclature, (v) miRNA sequence, (vi) length, (vii) GC content, (viii) pre-miRNA, (ix) arm, (x) cell line, (xi) experimental method and (xii) references.
<figure><img src="image_3.png" /><figcaption>**Figure 1.** VIRmiRNA architecture.</figcaption></figure>

Additionally in VIRmiRNA sub database, outputs of the basic local alignment search tool (BLAST)/Alignment of the seed and complete miRNA sequence with that of viral as well as cellular miRNAs are provided. Predicted secondary structure of viral miRNA is also incorporated in individual entry. In VIRmiRtar and AVIRmiR sub databases, important fields like target gene name, miRNA-binding region, i.e. untranslated region or coding sequences and seed position are also given wherever available.

The database is hyperlinked to other useful resources like UniProt, GO, GenBank, PubMed and Taxonomy browser. Also, other important miRNA related resources on the web are listed separately on the ‘Related Links’ page.

## Implementation

VIRmiRNA is organized to provide easy and user-friendly access to the data. It is hosted on Red Hat Linux machine using Apache web server. The web server is maintained in MySQL at back end, while front end is implemented with PHP language. Schematic representation of VIRmiRNA architecture is shown in Figure 1.

## Results

### Database statistics

VIRmiRNA resource encompasses experimentally validated information of 9133 entries divided into three subarchives, namely VIRmiRNA, VIRmiRtar and

AVIRmiR. Detailed statistics of each of the module is depicted in Figure 2.

VIRmiRNA subdatabase has information of 1308 viral miRNA including 538 isomiRs sequences that belong to 44 viruses infecting a range of host organisms, namely human (17 viruses), other mammals (16 viruses), birds (7 viruses), invertebrates (3 viruses) and plants (1 virus). It includes a maximum of 287 miRNAs of Pseudorabies virus (PRV) followed by 111 miRNAs of Rhesus lymphocryptovirus (RLCV) and miRNAs of other important viruses like EBV, Herpes simplex virus (HSV) and Duck enteritis virus (DEV) etc. (Supplementary Table S1). These miRNAs have been validated on different cell lines like IB-RS-2, PK-15, HEK, BC, chicken embryo fibroblasts (CEF), Vero cells etc. (Figure 2a). Experimental methods used were Northern blot, real-time polymerase chain reaction (RT-PCR), microarray analysis, cloning and next generation sequencing (NGS) (Figure 2d), out of which NGS was the most commonly used experimental platform to identify viral miRNAs.

VIRmiRtar harbors 7283 experimentally validated viral miRNA targets from 15 different viruses like EBV, Kaposi sarcoma-associated herpesvirus (KSHV), Human cytomegalovirus (HCMV) and HSV-1 etc. Maximum 3683 and 2126 miRNA targets have been reported for EBV and KSHV, respectively (Supplementary Table S2). Targets have been identified using different cell-lines like BC-1, body-cavity-based lymphoma cell line (BCBL), BC-3, Lymphoblastoid, MSB1, Jijoye and others (Figure 2b). These
<figure><img src="image_4.png" /><figcaption>**Figure 2.** VIRmiRNA statistics: Pie charts (a–c) representing statistical distribution of cell lines and bar graphs (d–f) depicting the statistical trend of experimental methods used in the three subdatabases viz VIRmiRNA, VIRmiRtar and AVIRmiR, respectively. NGS, next generation sequencing; RT-PCR, real-time PCR; CLIP, cross-linking immunoprecipitation.</figcaption></figure>

viral miRNA targets have been determined using different experimental methods like photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (21, 46), high-throughput sequencing and cross-linking immunoprecipitation (47, 48), RT-PCR (48), western blot (49), luciferase reporter assay (50), etc. (Figure 2e).

It has been reported earlier that some genes were being targeted by more than one miRNA (51, 52). Similar trend was observed for viral miRNA targets like CCNT2, BRWD1, BTBD3, FNDC3A, LCOR etc. that were under the regulation of multiple miRNAs as briefed in Table 1 and detailed in Supplementary Table S4.

The third submodule, i.e. AVIRmiR deals with small yet quite important data about antiviral miRNAs. It contains 542 antiviral miRNAs acting against 26 different viruses (Supplementary Table S3). These miRNAs were predominantly tested using HuH-7, HEK, A549, NIH-3T3 and HepG2 cell lines (Figure 2c). These miRNAs have been mostly validated using RT-PCR, luciferase reporter assay, microarray and northern blot (Figure 2f). It has been

described earlier that a miRNA can target numerous genes (51). We also found hsa-miR-181b-5p, hsa-miR-142-5p, hsa-let-7 regulate many genes as shown in Table 2 and Supplementary Table S5.

## Web server interface

We have provided search, advanced search and browse options to retrieve the desired data from each of the three different subdatabases.

## Database search

In the search menu option, user can select any of the three submodules to search for a given keyword in all or specific fields. The search output provides information on the various aspects of miRNAs, i.e. nomenclature, sequence, length, GC content, cell line, experimental method and reference. Additionally, internal links showing the output of tools like Seed BLAST/Align (8mer/7mer) of miRNA seed sequence with that of viral miRNA (VIRmiRNA) and
<table><caption>**Table 1.** Host genes targeted by multiple viral miRNAs</caption><thead><tr><th>S. No.</th><th>Target</th><th>Viral miRNAs</th><th>No. of miRNA</th><th>Description</th><th>UniProt ID</th><th>Reference</th></tr></thead><tbody><tr><td>1</td><td>CCNT2</td><td>kshv-miR-k12-7, ebv-miR-bart9, ebv-miR-bart1-3p, ebv-miR-bart10, kshv-miR-k12-5, kshv-miR-k12-1</td><td>6</td><td>Cyclin-T2</td><td>F2Z2C9</td><td>22100165, 22291592, 22473208</td></tr><tr><td>2</td><td>BRWD1</td><td>kshv-miR-k12-11, kshv-miR-k12-6-3p, ebv-miR-bart6-3p, ebv-miR-bart4, ebv-miR-bart3</td><td>5</td><td>Bromodomain and WD repeat-containing protein 1</td><td>Q9NSI6</td><td>22100165, 22291592</td></tr><tr><td>3</td><td>BTBD3</td><td>ebv-miR-bart8*, kshv-miR-k12-9, ebv-miR-bart10, kshv-miR-k12-5, ebv-miR-bart15</td><td>5</td><td>BTB/POZ domain-containing protein 3</td><td>F8WAQ4</td><td>22100165</td></tr><tr><td>4</td><td>FNDC3A</td><td>kshv-miR-k12-5, ebv-miR-bart6-3p, ebv-miR-bart2-5p, ebv-miR-bart14, ebv-miR-bart3</td><td>5</td><td>Fibronectin type III domain containing 3A, isoform CRA_f</td><td>G5E9X3</td><td>22100165, 22291592</td></tr><tr><td>5</td><td>LCOR</td><td>kshv-miR-k12-10b, kshv-miR-k12-4-3p, ebv-miR-bart9*, ebv-miR-bart19-3p, ebv-miR-bart4</td><td>5</td><td>Ligand-dependent corepressor</td><td>Q96JN0</td><td>22100165, 22291592</td></tr><tr><td>6</td><td>LMBR1</td><td>kshv-miR-k12-9*, ebv-miR-bart20-3p, kshv-miR-k12-6-3p, ebv-miR-bart3*, ebv-miR-bart15</td><td>5</td><td>Limb region 1 protein homolog</td><td>F8WDW0</td><td>22100165, 22291592</td></tr><tr><td>7</td><td>MEQ</td><td>mdv1-miR-m1, mdv1-miR-m2-5p, mdv1-miR-m3, mdv1-miR-m4, mdv1-miR-m5</td><td>5</td><td>Oncoprotein MEQ</td><td>Q9DGW5</td><td>16912324</td></tr><tr><td>8</td><td>MLL</td><td>kshv-miR-k12-9, ebv-miR-bart6-5p, ebv-miR-bart10, kshv-miR-k12-1, ebv-miR-bart19-3p</td><td>5</td><td>Histone-lysine N-methyltransferase 2A</td><td>Q03164</td><td>22100165, 22473208</td></tr><tr><td>9</td><td>NCOR1</td><td>kshv-miR-k12-12, ebv-miR-bart8, ebv-miR-bart20-3p, kshv-miR-k12-1, ebv-miR-bart16</td><td>5</td><td>Nuclear receptor corepressor 1</td><td>O75376</td><td>22100165</td></tr><tr><td>10</td><td>PRPF40A</td><td>kshv-miR-k12-10a, ebv-miR-bart19-3p, kshv-miR-k12-2, ebv-miR-bart14, ebv-miR-bhrf1-2</td><td>5</td><td>Pre-mRNA-processing factor 40 homolog A</td><td>H7BXZ7</td><td>22100165, 22291592</td></tr></tbody></table>

cellular ones (miRBase) is displayed. In search output, we have also provided sorting and filtering functionality. Also, we have made the search results interactive by interlinking a viral miRNA entry with its experimental/predicted targets. By clicking on the miRNA ID, user can get complete details of that record. Result of the search output for KSHV miRNA is shown in the Figure 3.

## Advanced search

Advanced search using logical operators helps the user to find the appropriate data stringently in each of the subdatabases. User can successively build the query by entering the desired keyword and selecting the corresponding field and logical operators (AND/OR). For example in *VIRmiRNA*, on searching EBV in the 'Virus' field, the output displays 52 entries, then by selecting 'Method' field as Northern blot, the output shows 46 entries. Further by choosing 'Length' field as 22, the final result output lists 26 entries.

## Database browsing

*VIRmiRNA* browse gives a list of viruses along with the number of miRNAs for that virus, e.g. HSV-1 has 48

miRNAs. On clicking a virus name, information of all the miRNAs encoded by that virus will be displayed, and further details can be viewed by clicking on its ID. In order to know the classification of the virus, we have also provided an external link to 'NCBI Taxonomy browser' for each virus. *VIRmiRtar* browse provides a list of viral miRNAs along with the number of their target genes. For example, ebv-miR-bart19-3p has maximum of 370 targets, which can be viewed by clicking on the particular miRNA. *AVIRmiR* browse displays a list of viruses along with the number of antiviral miRNAs and virus taxonomy.

## Analysis tools

We have also integrated various tools in *VIRmiRNA* like *Seed-Align*, *BLAST*, *Map* and *TarFind* for the analysis of the miRNA sequences. In *VIRmiRNA-Seed-Align*, user can align any given miRNA seed sequence against *VIRmiRNA* as well as cellular (miRBase) miRNAs. User has to provide the miRNA seed sequence in FASTA format. The output provides a list of matching seed sequences along with their
<table><caption>**Table 2.** Antiviral miRNAs targeting multiple viral genes</caption><thead><tr><th>S. No.</th><th>miRNA name</th><th>No. of targets</th><th>Target name</th><th>Virus name</th><th>Biological process involved</th><th>Reference</th></tr></thead><tbody><tr><td>1</td><td>hsa-miR-181b-5p</td><td>10</td><td>CD163, M1, M2, NA, NEP, NP, NS1, PA, PB1, PB2</td><td>INFV, VZV, PRRSV</td><td>Replication</td><td>WO/2010/101663/A2, 23740977, 22676898, 20643945, 20643939</td></tr><tr><td>2</td><td>hsa-miR-142-5p</td><td>10</td><td>M1, M2, NA, NEP, NP, NS1, PA, PB1, PB2, 3' UTR</td><td>INFV, DENV</td><td>Replication</td><td>22241991, WO/2010/101663/A2</td></tr><tr><td>3</td><td>hsa-let-7</td><td>9</td><td>Casp3, DICER1, HMGA2, IFN-beta, IGF2BP1, IGF2BP2, MYC, RAB40C, STAT3</td><td>HBV, VZV, HCV</td><td>Replication, translation, interferon system</td><td>21565290, 18668040, 23824794, 20969775, 18700235, 20643939</td></tr><tr><td>4</td><td>hsa-miR-149</td><td>9</td><td>M1, M2, NEP, NP, NS1, PA, PB1, PB2, vpr</td><td>HIV, INFV</td><td>Replication, translation</td><td>16236258, WO/2010/101663/A2</td></tr><tr><td>5</td><td>hsa-miR-16</td><td>9</td><td>M1, M2, Nef, NEP, NP, NS1, PA, PB1, PB2</td><td>INFV, HIV</td><td>Replication</td><td>22080513, WO/2010/101663/A2</td></tr><tr><td>6</td><td>hsa-miR-17-5p</td><td>9</td><td>M1, M2, Nef, NEP, NP, NS1, PA, PB1, PB2</td><td>INFV, HIV</td><td>Replication</td><td>17322031, WO/2010/101663/A2</td></tr><tr><td>7</td><td>hsa-miR-93</td><td>9</td><td>IRES, M1, M2, NEP, NP, NS1, PA, PB1, PB2</td><td>INFV, VSV</td><td>Replication</td><td>21431677, WO/2010/101663/A2</td></tr><tr><td>8</td><td>hsa-miR-122</td><td>8</td><td>5' UTR, CAT-1, CCNG1, HBsAg, HO-1, IFN-beta, NDRG3, SOX6</td><td>VZV, BDV, HCV</td><td>Replication, translation</td><td>20561966, 18431360, 21725618, 21565290, 21821155</td></tr><tr><td>9</td><td>hsa-miR-1259</td><td>8</td><td>M1, M2, NEP, NP, NS1, PA, PB1, PB2</td><td>INFV</td><td>Replication, interferon system</td><td>22676898, 20643939, 18431360, 20561966, 21565290, 21821155, 16141076</td></tr><tr><td>10</td><td>hsa-miR-1977</td><td>8</td><td>M1, M2, NEP, NP, NS1, PB1, PB2, PA</td><td>INFV</td><td>Replication</td><td>WO/2010/101663/A2</td></tr></tbody></table>

database accession numbers, nomenclature, alignment positions and percent identity values.

VIRmiRNA-BLAST searches the presence of miRNA sequences in the database matching the user provided miRNA sequence. The output shows both graphical and text alignment of the matching miRNA sequences along with their alignment score. VIRmiRNA-Map displays the perfectly matching miRNAs available in our database against a given nucleotide sequence. It helps user to find how many miRNAs are available in the database corresponding to the user provided sequence. VIRmiRNA-TarFind predicts the target genes in the human reference gene sequence against the user provided miRNA or seed sequence. VIRmiRNA-Update helps user to submit new viral miRNA information, which will be included in the main database after cross checking. We have also included 'How to use' and Frequently Asked Questions (FAQ) pages as well as 'help pop-ups' on individual pages to further assist the user to effectively use this resource. The 'How to use'

page is given with snapshots of input and output examples. Besides, user can download any of the three subdatabases from the 'Downloads' section.

## Discussion

miRNAs are considered as important noncoding RNA molecules playing a fundamental role in the regulation of cellular pathways (53, 54) and viral infection (16, 55). There are various experimentally validated miRNA databases reported in the literature like miRBase—a general miRNA storehouse (56), PMRD—a plant miRNA repository (34), miRCancer—a cancer-associated miRNA assemblage (57) etc. Of these only miRBase (56), the largest primary miRNA sequence repository, contains limited information on viral miRNAs. In VIRmiRNA, we have provided updated and comprehensive information on viral miRNAs from as many as 42 different viruses, which is 2-fold more than any existing resource. In addition, many resources of predicted
<figure><img src="image_5.png" /><figcaption>**Figure 3.** Schematic representation of the search output (a) a screenshot of search output returned in the tabular form having information regarding KSHV miRNAs, (b) Detailed information of kshv-miR-k12-2* miRNA, (c) and its interaction partners in graphical view.</figcaption></figure>

miRNAs like miRGen (58), miRWalk (39), mirDB (38), microRNA.org (35) also exist. However, for viral miRNA only a few predicted databases have been described like VirMirDb—a predicted viral miRNA database (41), vhotdb—a collection of predicted host-virus miRNA interactions (42) and miRNEST (43) but they do not furnish information on experimental viral miRNAs.

It has been reported that a single miRNA gene can express multiple isomiRs which differ between cell and tissue types (18). The isomiRs may either form an miRNA locus to coordinate target mRNA regulation (19) or their target transcripts could also potentially differ (17). VIRmiRNA also harbors knowledge about viral isomiRs that would be helpful in miRNA analysis. Studies have shown that some viral miRNAs have their orthologous cellular counterparts due to identical or partial overlap seed region. For e.g. kshv-miR-K12-11 has been reported to be orthologous to cellular miR-155 (59, 60), kshv-miR-K10a to miR-142-3p (21) and BLV-miR-B4 to hsa-miR-29 (61). For the analysis

of miRNA mimics, we have integrated seed align tool, which will be helpful to find miRNAs with identical seed region in both cellular and viral miRNAs.

There are a few repositories of experimentally validated miRNA targets viz. TarBase (36), miRNAMap 2.0 (62) and miRTarBase (37). Although miRTarBase has comprehensive information of miRNA targets from several organisms, but it has scarce data on viral miRNA targets. Simultaneously, there are many catalogues of predicted miRNA targets viz. TargetScan (63), PicTar (64), mirDB (38), DIANA microT (65), miRanda (51), ComiR (66). Moreover, databases of predicted viral miRNA targets are also available including ViTa—a database of predicted host miRNA targets on the viral genome (44) and RepTar—a repository of predicted cellular targets of mammalian as well as viral miRNAs (45). Comparatively, VIRmiRtar is the only database that holds updated and inclusive information of over 7000 experimental viral miRNA targets from 15 viruses.
It has been reported that multiple miRNAs bind to a single target gene, a phenomenon known as cooperativity (51, 52). Analysis of the target genes in VIRmiRtar showed that CCNT2, BRWD1, BTBD3, FNDC3A and LCOR etc. genes were targeted by several miRNAs. CCNT2 or Cyclin-T2 that functions as a regulator of CDK9 kinase (67) is being targeted by six miRNAs, belonging to KSHV and EBV, namely kshv-miR-k12-7, ebv-miR-bart9, ebv-miR-bart1-3p, ebv-miR-bart10, kshv-miR-k12-5 and kshv-miR-k12-1. Similarly, BRWD1 or Bromodomain and WD repeat-containing protein-1, that controls cell shape via the regulation of cytoskeletal organization (68) is being regulated by five viral miRNAs. Yet another gene BTBD3 or BTB/POZ domain-containing protein 3, that functions as a regulator of mammalian neurodevelopmental processes (69) is also being targeted by five different viral miRNAs. These and other important viral miRNA targets are briefly listed in Table 2.

Using KEGG Mapper, we found that the target genes in VIRmiRtar were enriched in several important cellular pathways including Metabolic (hsa01100), cancer (hsa05200), viral carcinogenesis (hsa05203) pathways with 188, 96 and 84 hits, respectively. Other important pathways with significant hits include viral infections, MAPK signaling pathway, PI3K-Akt and cell cycle (Supplementary File S2). Thus, the viral miRNA targets include a range of genes that regulate diverse biological pathways. The role of miRNAs as key gene regulators in different cellular pathways has further been reviewed (9, 70, 71).

Scientists have studied that viral pathogenesis is regulated by host miRNAs which target viral or cellular genes necessary for virus replication (72), e.g. eight interferon-β regulated human miRNAs have been found to target HCV (73). AVIRmiR is the only repository having information of host miRNAs showing antiviral effect. Research findings have stated that a particular miRNA targets more than one gene, a phenomenon termed as 'multiplicity' (51). In AVIRmiR, we found the similar observation that antiviral miRNAs target multiple genes e.g. hsa-miR-181b-5p, which functions as a tumor suppressor (74), inhibits ten viral genes from different viruses like influenza A virus (INFV A), Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Varicella-zoster virus (VZV) and Mink enteritis virus. Similarly, hsa-miR-142-5p targets nine different genes of INFV and Dengue virus (DENV), while hsa-miR-16 and hsa-miR-17-5p are reported to target nine different genes of human immunodeficiency virus (HIV) and INFV (Table 2). It appears from the trend of multiple gene regulation by antiviral miRNA that they are adapted to target genes critical for virus survival and thus play a vital role in host antiviral defense.

## Conclusion

Understanding different aspects of viral miRNA biology may be harnessed in combating viral infections. In VIRmiRNA resources, we have furnished updated and exhaustive information on experimentally validated viral encoded miRNAs with their isomiRs, the largest collection of their associated targets and the first catalogue of anti-viral miRNAs. This comprehensive resource along with the analysis tools would be useful in deciphering host-virus interactions and the development of miRNA based therapeutics against the pathogenic viruses.

## Future implications

In the future, our main focus will be to update the resource by including new viruses and targets, once the appropriate information is available in the literature.

## Supplementary Data

Supplementary data are available at *Database* Online.

## Acknowledgements

We are also grateful to the reviewers for their valuable and insightful suggestions, which helped in improving the resource.

## Funding

Council of Scientific and Industrial Research (BSC0121) and Department of Biotechnology (GAP001). Funding for open access charge: CSIR- Institute of Microbial Technology (GENESIS).

*Conflict of interest.* None declared.

## REFERENCES

1. Fire, A., Xu, S., Montgomery, M. K., et al. (1998) Potent and specific genetic interference by double-stranded RNA in *Caenorhabditis elegans*. *Nature*, **391**, 806–811.

2. Castanotto, D. and Rossi, J. J. (2009) The promises and pitfalls of RNA-interference-based therapeutics. *Nature*, **457**, 426–433.

3. Gomes, A. Q., Nolasco, S., Soares, H. (2013) Non-coding RNAs: multi-tasking molecules in the cell. *Int. J. Mol. Sci.*, **14**, 16010–16039.

4. Anglicheau, D., Muthukumar, T., Suthanthiran, M. (2010) MicroRNAs: small RNAs with big effects. *Transplantation*, **90**, 105–112.

5. Hannon, G. J. (2002) RNA interference. *Nature*, **418**, 244–251.

6. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. *Cell*, **116**, 281–297.

7. Guo, H., Ingolia, N. T., Weissman, J. S., et al. (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. *Nature*, **466**, 835–840.
8. Lee,R.C., Feinbaum,R.L., Ambros,V. (1993) The *C. elegans* heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. *Cell*, **75**, 843-854.

9. Bartel,D.P. (2009) MicroRNAs: target recognition and regulatory functions. *Cell*, **136**, 215-233.

10. Cimmino,A., Calin,G.A., Fabbri,M., et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. *Proc. Natl Acad. Sci. USA*, **102**, 13944-13949.

11. Xiao,C. and Rajewsky,K. (2009) MicroRNA control in the immune system: basic principles. *Cell*, **136**, 26-36.

12. Lodish,H.F., Zhou,B., Liu,G., et al. (2008) Micromanagement of the immune system by microRNAs. *Nat. Rev. Immunol.*, **8**, 120-130.

13. Pfeffer,S., Zavolan,M., Grasser,F.A., et al. (2004) Identification of virus-encoded microRNAs. *Science*, **304**, 734-736.

14. Glazov,E.A., Horwood,P.F., Assavalapsakul,W., et al. (2010) Characterization of microRNAs encoded by the bovine herpesvirus 1 genome. *J. Gen. Virol.*, **91**, 32-41.

15. Besecker,M.I., Harden,M.E., Li,G., et al. (2009) Discovery of herpes B virus-encoded microRNAs. *J. Virol.*, **83**, 3413-3416.

16. Gottwein,E. (2013) Roles of microRNAs in the life cycles of mammalian viruses. *Curr. Top Microbiol. Immunol.*, **371**, 201-227.

17. Morin,R.D., O'Connor,M.D., Griffith,M., et al. (2008) Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. *Genome Res.*, **18**, 610-621.

18. Tan,G.C., Chan,E., Molnar,A., et al. (2014) 5' isomiR variation is of functional and evolutionary importance. *Nucleic Acids Res.*, **42**, 9424-9435.

19. Guo,L., Chen,F. (2014) A challenge for miRNA: multiple isomiRs in miRNAomics. *Gene*, **544**, 1-7.

20. Skalsky,R.L. and Cullen,B.R. (2010) Viruses, microRNAs, and host interactions. *Annu. Rev. Microbiol.*, **64**, 123-141.

21. Gottwein,E., Corcoran,D.L., Mukherjee,N., et al. (2011) Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. *Cell Host Microb.*, **10**, 515-526.

22. Park,S.O., Kumar,M., Gupta,S. (2012) TGF-beta and iron differently alter HBV replication in human hepatocytes through TGF-beta/BMP signaling and cellular microRNA expression. *PLoS One*, **7**, e39276.

23. Ely,A., Naidoo,T., Mufamadi,S., et al. (2008) Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo. *Mol. Ther.*, **16**, 1105-1112.

24. van Rooij,E., Purcell,A.L., Levin,A.A. (2012) Developing microRNA therapeutics. *Circ. Res.*, **110**, 496-507.

25. Stenvang,J. and Kauppinen,S. (2008) MicroRNAs as targets for antisense-based therapeutics. *Expert Opin. Biol. Ther.*, **8**, 59-81.

26. Lennox,K.A., Owczarzy,R., Thomas,D.M., et al. (2013) Improved performance of anti-miRNA oligonucleotides using a novel non-nucleotide modifier. *Mol. Ther. Nucleic Acids*, **2**, e117.

27. Jopling,C.L., Schutz,S., Sarnow,P. (2008) Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. *Cell Host Microb.*, **4**, 77-85.

28. van Rooij,E., Sutherland,L.B., Qi,X., et al. (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. *Science*, **316**, 575-579.

29. Thai,T.H., Calado,D.P., Casola,S., et al. (2007) Regulation of the germinal center response by microRNA-155. *Science*, **316**, 604-608.

30. Liu,G., Friggeri,A., Yang Y., et al. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. *J. Exp. Med.*, **207**, 1589-1597.

31. Bonauer,A., Carmona,G., Iwasaki,M., et al. (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. *Science*, **324**, 1710-1713.

32. Rayner,K.J., Sheedy,F.J., Esau,C.C., et al. (2011) Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. *J. Clin. Invest.*, **121**, 2921-2931.

33. Griffiths-Jones,S., Grocock,R.J., van Dongen,S., et al. (2006) miRBase: microRNA sequences, targets and gene nomenclature. *Nucleic Acids Res.*, **34**, D140-D144.

34. Zhang,Z., Yu,J., Li,D., et al. (2010) PMRD: plant microRNA database. *Nucleic Acids Res.*, **38**, D806-D813.

35. Betel,D., Wilson,M., Gabow,A., et al. (2008) The microRNA.org resource: targets and expression. *Nucleic Acids Res.*, **36**, D149-D153.

36. Vergoulis,T., Vlachos,I.S., Alexiou,P., et al. (2012) TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. *Nucleic Acids Res.*, **40**, D222-D229.

37. Hsu,S.D., Lin,F.M., Wu,W.Y., et al. (2011) miRTarBase: a database curates experimentally validated microRNA-target interactions. *Nucleic Acids Res.*, **39**, D163-D169.

38. Wang,X. (2008) miRDB: a microRNA target prediction and functional annotation database with a wiki interface. *RNA*, **14**, 1012-1017.

39. Dweep,H., Sticht,C., Pandey,P., et al. (2011) miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. *J. Biomed. Inform.*, **44**, 839-847.

40. Xiao,F., Zuo,Z., Cai,G., et al. (2009) miRecords: an integrated resource for microRNA-target interactions. *Nucleic Acids Res.*, **37**, D105-D110.

41. Li,S.C., Shiau,C.K., Lin,W.C. (2008) Vir-Mir db: prediction of viral microRNA candidate hairpins. *Nucleic Acids Res.*, **36**, D184-D189.

42. Kim,H., Park,S., Min,H., et al. (2012) vHoT: a database for predicting interspecies interactions between viral microRNA and host genomes. *Arch. Virol.*, **157**, 497-501.

43. Szczesniak,M.W. and Makalowska,I. (2014) miRNEST 2.0: a database of plant and animal microRNAs. *Nucleic Acids Res.*, **42**, D74-D77.

44. Hsu,P.W., Lin,L.Z., Hsu,S.D., et al. (2007) ViTa: prediction of host microRNAs targets on viruses. *Nucleic Acids Res.*, **35**, D381-D385.

45. Elefant,N., Berger,A., Shein,H., et al. (2011) RepTar: a database of predicted cellular targets of host and viral miRNAs. *Nucleic Acids Res.*, **39**, D188-D194.

46. Hafner,M., Landthaler,M., Burger,L., et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. *Cell*, **141**, 129-141.

47. Chi,S.W., Zang,J.B., Mele,A., et al. (2009) Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. *Nature*, **460**, 479-486.
48. Riley, K.J., Rabinowitz, G.S., Yario, T.A., et al. (2012) EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. *EMBO J*, **31**, 2207-2221.

49. Lee, S.H., Kalejta, R.F., Kerry, J., et al. (2012) BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection. *Proc. Natl Acad. Sci. USA*, **109**, 9575-9580.

50. Skalsky, R.L., Corcoran, D.L., Gottwein, E., et al. (2012) The viral and cellular microRNA targetome in lymphoblastoid cell lines. *PLoS Pathog.*, **8**, e1002484.

51. John, B., Enright, A.J., Aravin, A., et al. (2004) Human MicroRNA targets. *PLoS Biol*, **2**, e363.

52. Nachmani, D., Stern-Ginossar, N., Sarid, R., et al. (2009) Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. *Cell Host Microb.*, **5**, 376-385.

53. Potenza, N. and Russo, A. (2013) Biogenesis, evolution and functional targets of microRNA-125a. *Mol. Genet. Genomics*, **288**, 381-389.

54. Foster, P.S., Plank, M., Collison, A., et al. (2013) The emerging role of microRNAs in regulating immune and inflammatory responses in the lung. *Immunol. Rev.*, **253**, 198-215.

55. Hicks, J.A. and Liu, H.C. (2013) Current state of Marek's disease virus microRNA research. *Avian Dis.*, **57**, 332-339.

56. Kozomara, A. and Griffiths-Jones, S. (2014) miRBase: annotating high confidence microRNAs using deep sequencing data. *Nucleic Acids Res.*, **42**, D68-D73.

57. Xie, B., Ding, Q., Han, H., et al. (2013) miRCancer: a microRNA-cancer association database constructed by text mining on literature. *Bioinformatics*, **29**, 638-644.

58. Alexiou, P., Vergoulis, T., Gleditzsch, M., et al. (2010) miRGen 2.0: a database of microRNA genomic information and regulation. *Nucleic Acids Res.*, **38**, D137-D141.

59. Gottwein, E., Mukherjee, N., Sachse, C., et al. (2007) A viral microRNA functions as an orthologue of cellular miR-155. *Nature*, **450**, 1096-1099.

60. Skalsky, R.L., Samols, M.A., Plaisance, K.B., et al. (2007) Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. *J. Virol.*, **81**, 12836-12845.

61. Kincaid, R.P., Burke, J.M., Sullivan, C.S. (2012) RNA virus microRNA that mimics a B-cell oncomiR. *Proc. Natl Acad. Sci. USA*, **109**, 3077-3082.

62. Hsu, S.D., Chu, C.H., Tsou, A.P., et al. (2008) miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes. *Nucleic Acids Res.*, **36**, D165-D169.

63. Lewis, B.P., Burge, C.B., Bartel, D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. *Cell*, **120**, 15-20.

64. Krek, A., Grun, D., Poy, M.N., et al. (2005) Combinatorial microRNA target predictions. *Nat. Genet.*, **37**, 495-500.

65. Paraskevopoulou, M.D., Georgakilas, G., Kostoulas, N., et al. (2013) DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. *Nucleic Acids Res.*, **41**, W169-W173.

66. Coronnello, C. and Benos, P.V. (2013) ComiR: Combinatorial microRNA target prediction tool. *Nucleic Acids Res.*, **41**, W159-W164.

67. Peng, J., Zhu, Y., Milton, J.T., et al. (1998) Identification of multiple cyclin subunits of human P-TEFb. *Genes Dev.*, **12**, 755-762.

68. Bai, S.W., Herrera-Abreu, M.T., Rohn, J.L., et al. (2011) Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration. *BMC Biol.*, **9**, 54.

69. Matsui, A., Tran, M., Yoshida, A.C., et al. (2013) BTBD3 controls dendrite orientation toward active axons in mammalian neocortex. *Science*, **342**, 1114-1118.

70. Pasquinelli, A.E. (2012) MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. *Nat. Rev. Genet.*, **13**, 271-282.

71. Ameres, S.L. and Zamore, P.D. (2013) Diversifying microRNA sequence and function. *Nat. Rev. Mol. Cell Biol.*, **14**, 475-488.

72. Swaminathan, G., Navas-Martin, S., Martin-Garcia, J. (2014) MicroRNAs and HIV-1 infection: antiviral activities and beyond. *J. Mol. Biol.*, **426**, 1178-1197.

73. Pedersen, I.M., Cheng, G., Wieland, S., et al. (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism. *Nature*, **449**, 919-922.

74. Shi, L., Cheng, Z., Zhang, J., et al. (2008) hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. *Brain Res.*, **1236**, 185-193.